ACTAS UROLOGICAS ESPANOLAS, vol.45, no.5, pp.359-365, 2021 (SCI-Expanded)
Objective: To investigate the diagnostic efficiency of systemic immune response (SII) in prostate cancer (PCa) in patients with PSA < 10 ng/ml undergoing fusion prostate biopsy.